Towards evidence-based pharmacotherapy in children
Elles Marleen Kemper1, Maruschka Merkus, Peter C Wierenga
1Department of Pharmacy, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. e.m.kemper@amc.nl
Paediatric Anaesthesia
|January 5, 2011
Summary
Pediatric pharmacotherapy faces challenges due to a lack of registered drugs for children, with many prescribed medications being off-label. Evidence-based approaches and new legislation aim to improve drug safety and efficacy in pediatric populations.
Area of Science:
- Pediatric pharmacology
- Drug development
- Clinical pharmacology
Background:
- Approximately 70% of drugs prescribed to children are unstudied, off-label, or unlicensed.
- Dosages are often extrapolated from adult studies without specific pediatric trials.
- Variability in prescribing exists, with some countries developing national formularies.
Purpose of the Study:
- To review current challenges in pediatric pharmacotherapy.
- To highlight the need for evidence-based drug use in children.
- To address the complexities of pediatric drug dosage and administration.
Main Methods:
- Review of current practices and literature on pediatric drug prescription.
- Analysis of factors influencing drug absorption, distribution, metabolism, and excretion in children.
- Examination of regulatory initiatives promoting pediatric drug investigation.
Main Results:
- Significant gap exists in registered drugs for pediatric use.
- Developmental variations in children complicate accurate dosing.
- Oral drug administration requires consideration of bioavailability, taste, and safety.
Conclusions:
- Urgent need for evidence-based pharmacotherapy in children.
- New legislation and research networks are crucial for advancing pediatric drug safety and efficacy.
- Addressing off-label prescribing is essential for improving child health outcomes.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications